Baulamycins A and B, broad-spectrum antibiotics identified as inhibitors of siderophore biosynthesis in Staphylococcus aureus and Bacillus anthracis.
about
Alternative pre-approved and novel therapies for the treatment of anthraxEmerging concepts promising new horizons for marine biodiscovery and synthetic biologyMicroscale Adaptation of In Vitro Transcription/Translation for High-Throughput Screening of Natural Product Extract Libraries.Breaking a pathogen's iron will: Inhibiting siderophore production as an antimicrobial strategyIron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.Discovery of cahuitamycins as biofilm inhibitors derived from a convergent biosynthetic pathwayThioesterase domain swapping of a linear polyketide tautomycetin with a macrocyclic polyketide pikromycin in Streptomyces sp. CK4412.Recent developments in understanding the iron acquisition strategies of gram positive pathogens.Characterization of microbial siderophores by mass spectrometry.Chemical and Biological Aspects of Nutritional Immunity - Perspectives for New Anti-infectives Targeting Iron Uptake Systems.Strategies for target identification of antimicrobial natural products.Flying under the radar: The non-canonical biochemistry and molecular biology of petrobactin from Bacillus anthracis.Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.Petrobactin Is Exported from Bacillus anthracis by the RND-Type Exporter ApeX.Staphylococcus aureus pathogenesis in diverse host environments.Synergy of synthesis, computation and NMR reveals correct baulamycin structures.From QCA (Quantum Cellular Automata) to Organocatalytic Reactions with Stabilized Carbenium Ions.Sugar-based bactericides targeting phosphatidylethanolamine-enriched membranes
P2860
Q28075453-9E9644FA-A563-4CF0-B318-DB4661C88016Q28080553-DAEF86AA-CF08-448C-BF90-CB277482D03DQ35683997-DEFFD5F7-E95B-476A-8241-A1BAEB51833EQ35688927-69DF2175-60B2-41FA-9F79-231A5D3FD8C6Q35862783-89804383-FB40-4D74-BF82-70CB8DC216B1Q35924624-A2F018C9-6704-4EDD-9BC2-A57CD4A06544Q37080940-2C169532-CF58-410C-AB0E-2420D3D885CDQ38415707-DA14BB35-7A50-40D0-9232-F6031ACB82D9Q38484539-FAA95653-B8FC-42A5-84F5-9F0A82FAA698Q38691254-08573B7E-E95B-45E4-A236-89D241F1B899Q38710256-E1D4E20C-EDE5-4F2E-BBD1-C211BBEDE90CQ38840952-570B2589-CE18-40C4-A878-CC741827FCA4Q39003164-A800E7F3-73CC-426C-A5A8-D272674B7352Q40050401-3E4198EB-DCEF-4216-8B0A-2FADE43BD3E0Q40365019-D8900B75-1EB9-425F-8137-83EB093AAB7EQ51562219-AFE65FE7-7378-4D64-B008-6F35110FBDA8Q51572169-CA6A04C6-45FC-4EBD-8F17-F045D57B9494Q59134773-3D1B5AC5-E09D-4489-83D2-8ABDE579F468
P2860
Baulamycins A and B, broad-spectrum antibiotics identified as inhibitors of siderophore biosynthesis in Staphylococcus aureus and Bacillus anthracis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Baulamycins A and B, broad-spe ...... aureus and Bacillus anthracis.
@ast
Baulamycins A and B, broad-spe ...... aureus and Bacillus anthracis.
@en
type
label
Baulamycins A and B, broad-spe ...... aureus and Bacillus anthracis.
@ast
Baulamycins A and B, broad-spe ...... aureus and Bacillus anthracis.
@en
prefLabel
Baulamycins A and B, broad-spe ...... aureus and Bacillus anthracis.
@ast
Baulamycins A and B, broad-spe ...... aureus and Bacillus anthracis.
@en
P2093
P2860
P356
P1476
Baulamycins A and B, broad-spe ...... aureus and Bacillus anthracis.
@en
P2093
David H Sherman
George E Chlipala
Isaiah Yim
Jamie B Scaglione
Michael M Schofield
Pamela J Schultz
Philip C Hanna
Sean A Newmister
Tyler D Nusca
P2860
P304
P356
10.1021/JA4115924
P407
P577
2014-01-17T00:00:00Z